Botanical Solution Inc.
Botanical Solution Inc. (BSI), a Delaware Corporation, has a proprietary R&D platform for truly sustainable and improved production of consistent and high- quality Advanced Botanical Materials (ABM). ABM-01 is the first ABM produced by the company, based on a tissue cultured plant called Quillaja saponaria. ABM-01 is the active ingredient used in two gold standard products, BSI’s biopesticide Quillibrium® and the adjuvant QS-21, used in modern vaccine development.
Latest News
Biostimulants
BioConsortia Appoints Matthew Mouw as Vice President of Business Development
Agricultural technology executive brings deep experience across biologicals, seed...
ABG Update Feature
AgriBusiness Global Report: The Future of Biostimulants: Key Market Trends, Single-Molecule Tech, Grower Adoption
Stephen Pearce, Chairman of Accumont, and Sebastian Bachem, CEO...
Agrochemicals
ADAMA Appoints Dr. Zhigang Hao as President and CEO and Sammy Leibowitz as Chief Financial Officer
Global leadership experience and deep ADAMA expertise to support...
Americas
Cogny Secures Brazil’s First Authorization for Industrial Use of GMOs in Biocontrol Inputs
Historic regulatory approval positions Cogny to advance biotechnology-driven biological...